Biote (BTMD) vs NewGenIvf Group (NIVF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Biote is the larger company by market cap ($39.7 million vs $2.2 million), about 17.9 times the size. On valuation, NewGenIvf Group trades at a lower forward P/E (0.0x vs 2.6x for Biote).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | NIVF |
|---|---|---|
| Share price | $1.17 | $0.0811 |
| Market cap | $39.66M | $2.21M |
| 1-day change | +5.41% | -23.49% |
| YTD return | -55.00% | — |
| 1-year return | -59.23% | — |
| 5-year return | -88.02% | — |
| P/E ratio (TTM) | 8.36 | 0.00 |
| Forward P/E | 2.60 | 0.00 |
| EPS (TTM) | $0.14 | $328.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.26 | $1,539.00 |
| 52-week low | $1.06 | $0.064 |
| Distance from 52-week high | -64.11% | -99.99% |
| Analyst consensus | none | none |
| Avg. price target upside | +123.08% | +156595.44% |
| Average volume | 230.14K | 23.97M |
| Shares outstanding | 28.68M | 27.29M |
| Employees | 223 | 87 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Biote is about 17.9 times larger than NewGenIvf Group by market value ($39.66M vs $2.21M).
- Biote trades at a higher earnings multiple (8.4x vs 0.0x trailing P/E).
About Biote
BTMD stock →biote Corp. operates in practice-building business within the hormone optimization space.
Healthcare · Medical Care Facilities · 223 employees
About NewGenIvf Group
NIVF stock →NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing.
Healthcare · Medical Care Facilities · 87 employees
BTMD vs NIVF FAQ
Which is bigger, Biote or NewGenIvf Group?
Biote (BTMD) is larger, with a market capitalization of $39.66M compared with $2.21M for NewGenIvf Group (NIVF).
Which has the lower P/E ratio, BTMD or NIVF?
NIVF has the lower trailing P/E at 0.0, versus 8.4 for BTMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Biote and NewGenIvf Group in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.